Clostridium difficile infection in patients with acute myelogenous leukemia and in patients undergoing allogeneic stem cell transplantation: Epidemiology and risk factor analysis

Biology of Blood and Marrow Transplantation

Volumn 20, Issue 6, 2014, Pages 823-828

  Vehreschild, Maria J G T ^a,b   Weitershagen, David ^a   Biehl, Lena M ^a   Tacke, Daniela ^a   Waldschmidt, Dirk ^a   Töx, Ulrich ^a   Wisplinghoff, Hilmar ^c   Bergwelt Baildon, Michael v ^a   Cornely, Oliver A ^a,d,e   Vehreschild, Joerg J ^a,b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b German Center for Infection Research (DZIF)   (Germany)

^c UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^d UNIVERSITY OF COLOGNE   (Germany)

^e UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Acute myelogenous leukemia; Allogeneic stem cell transplantation; Carbapenem; Clostridium difficile infection

Indexed keywords

CARBAPENEM; METRONIDAZOLE; VANCOMYCIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CHEMOTHERAPY; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; ALLOTRANSPLANTATION; CLOSTRIDIUM INFECTIONS; COHORT ANALYSIS; GERMANY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOSUPPRESSIVE TREATMENT; ISOLATION AND PURIFICATION; LEUKEMIA, MYELOID, ACUTE; MICROBIOLOGY; MIDDLE AGED; PEPTOCLOSTRIDIUM DIFFICILE; PROCEDURES; PROSPECTIVE STUDY; STANDARDS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COHORT STUDIES; GERMANY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, MYELOID, ACUTE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 84899978622     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2014.02.022     Document Type: Article

References (27)

1. Bauer M.P., Kuijper E.J., van Dissel J.T., et al. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): Treatment guidance document for Clostridium difficile infection (CDI). Clin Microbiol Infect 2009, 15:1067-1079.
2. Cohen S.H., Gerding D.N., Johnson S., et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society For Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010, 31:431-455.
3. Slimings C., Riley T.V. Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis. J Antimicrob Chemother 2014, 69:881-891.
4. Schalk E., Bohr U.R., Konig B., et al. Clostridium difficile-associated diarrhoea, a frequent complication in patients with acute myeloid leukaemia. Ann Hematol 2010, 89:9-14.
5. Gorschluter M., Marklein G., Hofling K., et al. Abdominal infections in patients with acute leukaemia: a prospective study applying ultrasonography and microbiology. Br J Haematol 2002, 117:351-358.
6. Leung S., Metzger B.S., Currie B.P. Incidence of Clostridium difficile infection in patients with acute leukemia and lymphoma after allogeneic hematopoietic stem cell transplantation. Infect Control Hosp Epidemiol 2010, 31:313-315.
7. Trifilio S.M., Pi J., Mehta J. Changing epidemiology of Clostridium difficile-associated disease during stem cell transplantation. Biol Blood Marrow Transplant 2013, 19:405-509.
8. Willems L., Porcher R., Lafaurie M., et al. Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcome. Biol Blood Marrow Transplant 2012, 18:1295-1301.
9. Dubberke E.R., Reske K.A., Srivastava A., et al. Clostridium difficile-associated disease in allogeneic hematopoietic stem-cell transplant recipients: risk associations, protective associations, and outcomes. Clin Transplant 2010, 24:192-198.
10. Chakrabarti S., Lees A., Jones S.G., Milligan D.W. Clostridium difficile infection in allogeneic stem cell transplant recipients is associated with severe graft-versus-host disease and non-relapse mortality. Bone Marrow Transplant 2000, 26:871-876.
11. Alonso C.D., Treadway S.B., Hanna D.B., et al. Epidemiology and outcomes of Clostridium difficile infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2012, 54:1053-1063.
12. Talpaert M.J., Gopal Rao G., Cooper B.S., Wade P. Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection. J Antimicrob Chemother 2011, 66:2168-2174.
13. Aldeyab M.A., Devine M.J., Flanagan P., et al. Multihospital outbreak of Clostridium difficile ribotype 027 infection: epidemiology and analysis of control measures. Infect Control Hosp Epidemiol 2011, 32:210-219.
14. Freifeld A.G., Bow E.J., Sepkowitz K.A., et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 2011, 52:e56-e93.
15. von Elm E., Altman D.G., Egger M., et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Medicine 2007, 4:e296.
16. Paul M., Yahav D., Fraser A., Leibovici L. Empirical antibiotic monotherapy for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials. J Antimicrob Chemother 2006, 57:176-189.
17. Jenq R.R., Ubeda C., Taur Y., et al. Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation. J Exp Med 2012, 209:903-911.
18. Nordrhein Ä. Berufsordnung für die nordrheinischen Ärztinnen und Ärzte. In: Nordrhein Ä, ed; 2011.
19. Nordrhein-Westfalen L. Gesetz zum Schutz personenbezogener Daten im Gesundheitswesen (Gesundheitsdatenschutzgesetz - GDSG NRW). ; 1999 [German]. https://recht.nrw.de.
20. Gorschluter M., Glasmacher A., Hahn C., et al. Clostridium difficile infection in patients with neutropenia. Clin Infect Dis 2001, 33:786-791.
21. Altclas J., Requejo A., Jaimovich G., et al. Clostridium difficile infection in patients with neutropenia. Clin Infect Dis 2002, 34:723.
22. Dettenkofer M., Ebner W., Bertz H., et al. Surveillance of nosocomial infections in adult recipients of allogeneic and autologous bone marrow and peripheral blood stem-cell transplantation. Bone Marrow Transplant 2003, 31:795-801.
23. Ubeda C., Taur Y., Jenq R.R., et al. Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J Clin Invest 2010, 120:4332-4341.
24. van Nood E., Dijkgraaf M.G., Keller J.J. Duodenal infusion of feces for recurrent Clostridium difficile. N Engl J Med 2013, 368:2145.
25. Loo V.G., Poirier L., Miller M.A., et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005, 353:2442-2449.
26. Warny M., Pepin J., Fang A., et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005, 366:1079-1084.
27. Bauer M.P., Notermans D.W., van Benthem B.H., et al. Clostridium difficile infection in Europe: a hospital-based survey. Lancet 2011, 377:63-73.